Company / Operating Cash Flow
PLIANT THERAPEUTICS, INC. Operating Cash Flow History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$155.5M
FY2025
5-year range
-$155.5M / -$2.8M
FY2021-FY2025
Trend
-64.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$75M to -$156M over the past 2 years.
Based on SEC 10-K filings.
-$156M in FY2025.
Declined from -$75M to -$156M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow decreased 64.3% year-over-year.
- Peak operating cash flow was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -4.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$155.5M | -64.3% |
| FY2024 | -$94.6M | -25.4% |
| FY2023 | -$75.4M | +0.0% |
| FY2022 | -$75.4M | -2643.4% |
| FY2021 | -$2.8M | +0.0% |
| FY2020 | -$2.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026